Development of Visual Function Evaluation Method (2)

Astellas

Status: Completed

Conditions: Retinitis Pigmentosa

Study type: Observational

Funder types: Industry

Identifiers

NCT03626207

CLR180001

Details and patient eligibility

About

The objective of this study is to develop the comprehensive visual function evaluation method in severe visually impaired patient.

Enrollment: 8 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with severe visual disturbance (count-fingers or worse vision for severe eyes) at the time of obtaining the consent and at screening

Exclusion criteria

• Subjects should not have participated in any other clinical trial or clinical study involving visual function evaluation within 6 months
• History of surgery, past history, and complications (cardiac/ hepatic/ renal/ respiratory/ hematological diseases, optic nerve diseases causing marked loss of visual field, and uveitis etc.) that potentially affect evaluation and safety of the study
• Pregnant women
• Subjects who are judged that continuation of the study is difficult during the study period
• Subjects who are employed by the company sponsoring this study, an organization or institution related to this study

Trial design

8 participants in 1 patient group

Retinitis pigmentosa

Description:

Retinitis pigmentosa patients with severe visual impairment